Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves’ Ophthalmopathy

Table 3

Number of patients and the percentage of (a) TCR and (b) CD3 expression within scores 0, 1, and 2 in examined groups (see the footer of Table 2).

(a)

TCR expression	Control	Mild GO	Severe GO	Sum
≤10%	7	2	0	9
%	100.0%	33.34%	0.00%
10%–50%	0	4	13	17
%	0.00%	66.66%	65.00%
>50%	0	0	7	7
%	0.00%	0.00%	35.00%

(b)

CD3 expression	Control	Mild GO	Severe GO	Sum
≤10%	7	2	0	9
%	100.0%	33.34%	0%
10%–50%	0	4	19	24
%	0.0%	66.66%	95%
>50%	0	0	1	1
%	0.00%	0.00%	5%